Literature DB >> 35867164

Premenstrual exacerbation of mental health disorders: a systematic review of prospective studies.

Louise Nora Nolan1, Liz Hughes2.   

Abstract

Mental health disorders can be exacerbated during periods of hormonal fluctuation (e.g. pregnancy, menopause), and the risk factors for sensitivity to these fluctuations are similar to those of mental disorders (e.g. trauma). However, the extent to which hormonal fluctuations during the menstrual cycle impact symptoms of preexisting mental disorders remains unclear. Prospective methodology is considered the gold standard for measuring symptoms across the menstrual cycle. Thus, the aim of the review was to address this knowledge gap by summarising all available studies prospectively measuring symptoms of mental disorders across the menstrual cycle. A systematic review with narrative synthesis was conducted; meta-analysis was precluded due to methodological heterogeneity of included studies. Electronic databases MEDLINE, Embase, PyschINFO and CINAHL were systematically searched from inception. Risk of bias for individual studies was assessed using a modified version of the Newcastle-Ottawa Scale. The search identified 629 studies from which 35 met inclusion criteria. There was clear evidence of symptom exacerbation during the perimenstrual phase for psychotic disorders, panic disorder, eating disorders, depression and borderline personality disorder. Less consistent evidence was found for anxiety, and a different pattern of symptom exacerbation was observed in bipolar disorder. Sample size and methodology varied considerably amongst studies. Overall, there was mixed evidence for perimenstrual exacerbation across mental disorders, which could be partly explained by methodological limitations of the studies. However, hormonal fluctuations during the menstrual cycle may exacerbate psychiatric symptoms in a subgroup of individuals who are hormone sensitive.
© 2022. Crown.

Entities:  

Keywords:  Menstrual cycle; Mental health disorders; Premenstrual disorders; Systematic review

Mesh:

Substances:

Year:  2022        PMID: 35867164     DOI: 10.1007/s00737-022-01246-4

Source DB:  PubMed          Journal:  Arch Womens Ment Health        ISSN: 1434-1816            Impact factor:   4.405


  65 in total

1.  GRADE guidelines: 3. Rating the quality of evidence.

Authors:  Howard Balshem; Mark Helfand; Holger J Schünemann; Andrew D Oxman; Regina Kunz; Jan Brozek; Gunn E Vist; Yngve Falck-Ytter; Joerg Meerpohl; Susan Norris; Gordon H Guyatt
Journal:  J Clin Epidemiol       Date:  2011-01-05       Impact factor: 6.437

2.  Bayesian adaptive regression splines for hierarchical data.

Authors:  Jamie L Bigelow; David B Dunson
Journal:  Biometrics       Date:  2007-04-02       Impact factor: 2.571

3.  Estrogen, menstrual cycle phases, and psychopathology in women suffering from schizophrenia.

Authors:  Niels Bergemann; Peter Parzer; Benno Runnebaum; Franz Resch; Christoph Mundt
Journal:  Psychol Med       Date:  2007-04-24       Impact factor: 7.723

Review 4.  Estrogen Receptors Modulation of Anxiety-Like Behavior.

Authors:  A P Borrow; R J Handa
Journal:  Vitam Horm       Date:  2016-10-13       Impact factor: 3.421

5.  Menstrual fluctuation in the symptoms of panic anxiety.

Authors:  O G Cameron; D Kuttesch; K McPhee; G C Curtis
Journal:  J Affect Disord       Date:  1988 Sep-Oct       Impact factor: 4.839

6.  Changes in premenstrual symptoms in women with schizophrenia: a prospective study.

Authors:  S H Choi; S B Kang; S H Joe
Journal:  Psychosom Med       Date:  2001 Sep-Oct       Impact factor: 4.312

Review 7.  Late luteal phase dysphoric disorder (premenstrual syndromes): clinical implications.

Authors:  S J Blumenthal; C C Nadelson
Journal:  J Clin Psychiatry       Date:  1988-12       Impact factor: 4.384

8.  Lithium and valproate serum level fluctuations within the menstrual cycle: a systematic review.

Authors:  Claudia Carmassi; Claudia Del Grande; Isabella Masci; Danila Caruso; Laura Musetti; Andrea Fagiolini; Liliana Dell'Osso
Journal:  Int Clin Psychopharmacol       Date:  2019-05       Impact factor: 1.659

9.  Toward validation of atypical depression in the community: results of the Zurich cohort study.

Authors:  Jules Angst; Alex Gamma; Robert Sellaro; Heping Zhang; Kathleen Merikangas
Journal:  J Affect Disord       Date:  2002-11       Impact factor: 4.839

10.  Neurosteroid secretion in panic disorder.

Authors:  Francesca Brambilla; Giovanni Biggio; Maria Giuseppina Pisu; Laura Bellodi; Giampaolo Perna; Vesna Bogdanovich-Djukic; Robert H Purdy; Mariangela Serra
Journal:  Psychiatry Res       Date:  2003-05-30       Impact factor: 3.222

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.